108 related articles for article (PubMed ID: 9337689)
1. Interval cancers and cancers in non-attenders in the Ostergötland Mammographic Screening Programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence.
Vitak B; Stål O; Månson JC; Thomas BA; Arnesson LG; Ekelund L; Måre K; Nordenskjöld B; Källström AC; Bång H
Eur J Cancer; 1997 Aug; 33(9):1453-60. PubMed ID: 9337689
[TBL] [Abstract][Full Text] [Related]
2. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
3. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
[TBL] [Abstract][Full Text] [Related]
4. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers.
Vitak B; Olsen KE; Månson JC; Arnesson LG; Stål O
Eur Radiol; 1999; 9(3):460-9. PubMed ID: 10087117
[TBL] [Abstract][Full Text] [Related]
5. Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program.
Hatschek T; Fagerberg G; Stål O; Sullivan S; Carstensen J; Gröntoft O; Nordenskjöld B
Cancer; 1989 Sep; 64(5):1074-81. PubMed ID: 2758384
[TBL] [Abstract][Full Text] [Related]
6. Invasive interval cancers in the Ostergötland Mammographic Screening Programme: radiological analysis.
Vitak B
Eur Radiol; 1998; 8(4):639-46. PubMed ID: 9569340
[TBL] [Abstract][Full Text] [Related]
7. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
8. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
9. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
10. Mammographic screening reduces risk of breast carcinoma recurrence.
Immonen-Räihä P; Kauhava L; Parvinen I; Holli K; Kronqvist P; Pylkkänen L; Helenius H; Kaljonen A; Räsänen O; Klemi PJ
Cancer; 2005 Feb; 103(3):474-82. PubMed ID: 15611974
[TBL] [Abstract][Full Text] [Related]
11. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
12. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.
Porter PL; El-Bastawissi AY; Mandelson MT; Lin MG; Khalid N; Watney EA; Cousens L; White D; Taplin S; White E
J Natl Cancer Inst; 1999 Dec; 91(23):2020-8. PubMed ID: 10580027
[TBL] [Abstract][Full Text] [Related]
13. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
14. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
15. Aspects in mammographic screening. Detection, prediction, recurrence and prognosis.
Thurfjell MG
Acta Radiol Suppl; 2001 Dec; 42(424):1-22. PubMed ID: 12040855
[TBL] [Abstract][Full Text] [Related]
16. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
17. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
18. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
19. Interval cancers in a French breast cancer-screening programme (Somme Department).
Ganry OF; Peng J; Raverdy NL; Dubreuil AR
Eur J Cancer Prev; 2001 Jun; 10(3):269-74. PubMed ID: 11432715
[TBL] [Abstract][Full Text] [Related]
20. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
Zackrisson S; Janzon L; Manjer J; Andersson I
J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
